SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001578563-24-000183
Filing Date
2024-04-03
Accepted
2024-04-03 16:01:16
Documents
2
Period of Report
2024-03-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1470
2 POAKANTOFF poaakantoff.txt EX-24 3275
  Complete submission text file 0001578563-24-000183.txt   6332
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS CAMBRIDGE X0 CB22 3FH
Business Address
KANTOFF AARON (Reporting) CIK: 0001862734 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37590 | Film No.: 24818590